Tyler R. Call
No Rating Available
(Learn About Our Rating System)

Tyler R. Call, MD

Languages spoken: English

Dr. Call is the Medical Director of the operating rooms at both the Huntsman Cancer Hospital (HCH) and the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women's Cancers (KFK). He also serves at the Director of Anesthesia Services at these sites. His clinical focus is on periopertive care of the cancer patient and the majority of his current research endevors are in collaboration with oncologic surgeons here at HCH and KFK.

Specialties

Board Certification

American Board of Anesthesiology

Dr. Call is the Medical Director of the operating rooms at both the Huntsman Cancer Hospital (HCH) and the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women's Cancers (KFK). He also serves at the Director of Anesthesia Services at these sites. His clinical focus is on periopertive care of the cancer patient and the majority of his current research endevors are in collaboration with oncologic surgeons here at HCH and KFK.

Board Certification and Academic Information

Academic Departments Anesthesiology -Associate Professor (Clinical)
Board Certification
American Board of Anesthesiology

Education history

Undergraduate Brigham Young University Hawaii/Provo
Undergraduate University of Utah B.S.
Professional Medical Medicine - State University of New York, Upstate Medical University M.D.
Internship Transitional Year - St. Josephs Hospital in Syracuse New York Transitional Internship
Residency Anesthesiology - University of Utah Resident
Fellowship Anesthesiology - Huntsman Cancer Hospital Clinical Research Fellow

Selected Publications

Journal Article

  1. Boesl MA, Brown N, Bleicher J, Call T, Lambert DH, Lambert L (2024). Continuous Wound Irrigation and Intraoperative Methadone Decreases Opioid Use and Shortens Length of Stay After CRS/HIPEC. Annals of surgical oncology, 31(6), 3742-3749.
  2. Campsen J, Call T, Allen CM, Presson AP, Martinez E, Rofaiel G, Kim R (2019). Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant. American journal of transplantation, 19(6), 1777-1781.